The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021

A Method of Trace Iodination of Proteins for Immunologic Studies

1966 • 2,148 citations

Untersuchungen am überlebenden Säugethierherzen

1895 • 1,322 citations

LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS

1972 • 1,214 citations

The role of platelet-activating factor in platelet aggregation

1979 • 408 citations

BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER)

1981 • 332 citations

Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. studies with paf-receptor antagonist kadsurenone

1985 • 298 citations

Is platelet activating factor (PAF) a mediator of endotoxin shock?

1985 • 247 citations

Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs

1983 • 243 citations

BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L.

1985 • 207 citations

Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.

1984 • 203 citations

The heart as a target organ in systemic allergic reactions: comparison of cardiac analphylaxis in vivo and in vitro.

1975 • 130 citations

Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988

1986 • 124 citations

Specific binding sites for platelet activating factor in human lung tissues

1985 • 117 citations

Paf-acether: a mediator of inflammation and asthma

1984 • 113 citations

The effect of 1-O-alkyl-2-acetyl-Sn-glycero- 3-phosphocholine (paf-acether) on the arterial wall

1985 • 81 citations

Progress in Lipid Research

2009 • 81 citations

In vivo inhibition of plasma protein leakage andSalmonella enteritidis—induced mortality in the rat by a specific paf-acether antagonist: BN 52021

1986 • 72 citations

Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether

1985 • 54 citations

ANTIGEN‐INDUCED BRONCHIAL ANAPHYLAXIS IN ACTIVELY SENSITIZED GUINEA‐PIGS: ANTI‐ANAPHYLACTIC EFFECTS OF SODIUM CROMOGLYCATE AND AMINOPHYLLINE

1980 • 51 citations

Hypotensive activity of PAF-acether in rats

1982 • 43 citations

Platelet-activating factor

1980 • 42 citations

Effect of inhibition of synthesis and receptor antagonism of SRS‐ A in cardiac anaphylaxis

1983 • 40 citations

Hypotensive and vasodilatory activity of (±) 1-0-octadecyl-2-acetyl glyceryl-3-phosphorylcholine in the normotensive rat

1983 • 40 citations

Involvement of leukotrienes and PAF-acether in the increased microvascular permeability of the rabbit retina

1984 • 36 citations

Inhibition of rabbit platelet aggregation by the Ca2+-antagonists verapamil and diltiazem and by trifluoperazine

1983 • 35 citations

Cardiovascular and renal action of platelet-activating factor in anesthetized dogs.

1984 • 34 citations

Regional hemodynamic effects of antihypertensive renomedullary lipids in conscious rats.

1984 • 28 citations

Aortic vascular and atrial responses to (±)‐1‐O‐octadecyl‐2‐acetyl‐glyceryl‐3‐phosphorylcholine

1983 • 26 citations

α‐ADRENORECEPTOR‐MEDIATED PHASIC AND TONIC ACTIVITY IN RAT PORTAL VEIN IN VITRO

1983 • 14 citations

Extrapancreatic effects of hypoglycemic sulfonylureas: still a controversial issue

1985 • 11 citations

Effects of compound 48/80 on the guinea-pig isolated heart: A comparison with the in vitro cardiac anaphylaxis

1981 • 7 citations

EFFECTS OF DILTIAZEM ON PHASIC AND TONIC ACTIVITY IN RAT PORTAL VEIN

1983 • 5 citations

Platelets activating factor

1993 • 1 citations

Deleted Work

1955 • 0 citations